Illumina, Inc. and Sequoia Capital China jointly announced the selection of the first two startup companies joining the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina. Located in Zhangjiang Cell Industrial Park, Shanghai, the incubator will serve as a company creation engine focused on supporting life sciences startup companies who are poised to deliver breakthrough applications in genomics and multiomics. The startups selected for the inaugural funding cycle are: Mobidrop Biotechnology, a medical device and research tools company developing cutting-edge, single-cell sequencing microfluidic technologies for molecular diagnostics applications. Sequanta Technologies, a multiomics company committed to building DNA, RNA, epitome, and proteomics technology platforms for research and clinical applications. Startups will be selected twice a year to join the incubator for a six-month funding cycle. Sequoia Capital China will provide them with access to investment and business guidance, and they will work with Illumina sequencing systems and reagents in a fully operational lab space, accessing Illumina's genomics and business expertise.